TINA QUANT IGM * 1929305

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2002-02-21 for TINA QUANT IGM * 1929305 manufactured by Roche - Gmbh.

Event Text Entries

[19076464] Precipitate in specific lots of clinical chemistry reagent can lead to falsely high or low results; when run on analyzer.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1823260-2002-00061
MDR Report Key378793
Report Source05
Date Received2002-02-21
Date of Report2002-02-20
Date of Event2002-01-30
Date Mfgr Received2002-01-30
Device Manufacturer Date2001-03-01
Date Added to Maude2002-02-28
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactDEBARA REEK
Manufacturer Street9115 HAGUE RD.
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175763857
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Remedial ActionRC
Previous Use Code3
Removal Correction Number1823260-02/08/02-001-R
Event Type3
Type of Report3

Device Details

Brand NameTINA QUANT IGM
Generic NameCLINICAL CHEMISTRY REAGENT
Product CodeDAO
Date Received2002-02-21
Model Number*
Catalog Number1929305
Lot Number62246301
ID Number*
Device Expiration Date2002-08-31
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeNA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE - GMBH
Manufacturer AddressSANDOFER STRASSE 116 MANNHEIM D-68298 * D-68298
Baseline Brand NameTINA QUANT IGM
Baseline Generic NameIMMUNOASSAY
Baseline Model NoNA
Baseline Catalog No1929305
Baseline IDNA
Baseline Device FamilyHITACHI FAMILY OF ANALYZERS
Baseline Shelf Life Contained*
Baseline Shelf Life [Months]22
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK955908
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
10 2002-02-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.